These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19787208)

  • 1. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
    Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
    Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
    Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
    Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
    Banno K; Yanokura M; Iida M; Masuda K; Aoki D
    J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer.
    Yanokura M; Banno K; Kawaguchi M; Hirao N; Hirasawa A; Susumu N; Tsukazaki K; Aoki D
    Oncol Rep; 2007 Jan; 17(1):41-8. PubMed ID: 17143476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.
    Kondo E; Furukawa T; Yoshinaga K; Kijima H; Semba S; Yatsuoka T; Yokoyama T; Fukushige S; Horii A
    Int J Oncol; 2000 Sep; 17(3):535-41. PubMed ID: 10938395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
    Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
    Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.
    Kawaguchi M; Yanokura M; Banno K; Kobayashi Y; Kuwabara Y; Kobayashi M; Nomura H; Hirasawa A; Susumu N; Aoki D
    Int J Oncol; 2009 Jun; 34(6):1541-7. PubMed ID: 19424571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
    Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
    Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients.
    Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J
    Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
    Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
    Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
    Zhou XC; Dowdy SC; Podratz KC; Jiang SW
    Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
    Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
    Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
    Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
    Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
    Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.